‘Keep them well’: New cystic fibrosis medications move closer to a cure
amina zafar
Results of a new drug trial suggest the next generation of medications, known as CFTR modulators, show potential to correct the genetic defect that causes cystic fibrosis and halt the disease’s destructive progression.
